OPRX

Peers: DOCS PHR DH GDRX VEEV HCAT CERT IQV ZD MGNI

| Held by: VTI DFSV VXF IWC ITOT DFMC DFAS EES FDHT AVSC

Index	-
Market Cap	177.53M
Enterprise Value	172.91M
Income	4.60M
Sales	98.65M
Book/sh	6.96
Cash/sh	1.28
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	133
IPO	May 18, 2005

P/E	40.07
Forward P/E	9.03
PEG	14.33
P/S	1.80
P/B	1.35
P/C	7.37
P/FCF	9.54
EV/EBITDA	11.10
EV/Sales	1.75
Quick Ratio	5.58
Current Ratio	5.58
Debt/Eq	0.15
LT Debt/Eq	0.14
Option/Short	Yes / Yes

EPS (ttm)	0.24
EPS next Y	1.04
EPS next Q	0.16
EPS this Y	-16.57%
EPS next Y	19.18%
EPS next 5Y	0.63%
EPS past 3/5Y	- -
Sales past 3/5Y	20.56% 20.37%
EPS Y/Y TTM	145.91%
Sales Y/Y TTM	-5.82%
EPS Q/Q	-146.40%
Sales Q/Q	-29.77%
Earnings	Nov 11 AMC
EPS/Sales Surpr.	44.01% 1.47%

Insider Own	14.99%
Insider Trans	0.00%
Inst Own	69.34%
Inst Trans	-10.41%
ROA	2.76%
ROE	3.68%
ROIC	3.09%
Gross Margin	68.88%
Oper. Margin	11.45%
Profit Margin	4.66%
SMA20	6.43%
SMA50	14.44%
SMA200	29.43%
Trades

Shs Outstand	18.83M
Shs Float	16.01M
Short Float	6.74%
Short Ratio	5.92
Short Interest	1.08M
52W High	21.09 -55.31%
52W Low	4.54 107.60%
Volatility	3.52% 4.98%
ATR (14)	0.42
RSI (14)	65.17
Beta	1.20
Rel Volume	0.71
Avg Volume	182.05K
Volume	87,329

Perf Week	3.91%
Perf Month	9.98%
Perf Quarter	37.59%
Perf Half Y	39.22%
Perf YTD	-23.12%
Perf Year	-54.00%
Perf 3Y	13.42%
Perf 5Y	-90.22%
Perf 10Y	214.17%
Recom	1.00
Target Price	12.60
Prev Close	9.32
Price	9.43
Change %	1.13%

Consensus

Strong Buy

Avg. Price Target

$12.60

Implied Upside

+33.7%

Analysts8incl. previous ratings

Rating Distribution5 Buy · 3 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Sep 29, 2026	Resumed	RB. Riley Securities	Buy	$11	+16.7%
Jan 08, 2025	Downgrade	RRBC Capital Mkts	Outperform → Sector Perform	$7 → $6	-36.3%
Dec 20, 2024	Initiated	SStephens	Equal-Weight	$5.50	-41.6%
Jul 25, 2024	Resumed	RB. Riley Securities	Buy	$18.50	+96.3%
Apr 04, 2024	Initiated	JJMP Securities	Mkt Outperform	$15	+59.2%
Jan 03, 2024	Initiated	BBarclays	Equal Weight	$15	+59.2%
Feb 02, 2023	Resumed	RB. Riley Securities	Buy	$30	+218.3%
Nov 01, 2022	Initiated	SStifel	Buy	$19	+101.6%
Jul 15, 2022	Initiated	SSVB Leerink	Outperform	$38	+303.2%
Oct 18, 2021	Resumed	RB. Riley Securities	Buy	$102	+982.2%
Apr 13, 2021	Initiated	RRBC Capital Mkts	Outperform	$65	+589.7%
Jan 03, 2019	Initiated	WWilliam Blair	Outperform

Oct-28-26 07:30AM	OptimizeRx Sets Third Quarter 2026 Conference Call for November 11, 2026 at 4:30 p.m. ET (GlobeNewswire)
Oct-27-26 07:30AM	OptimizeRx and PulsePoint Partner to Connect HCP Media Across the Funnel (GlobeNewswire)
Sep-22-26 01:18PM	OptimizeRx Partners With The Trade Desk To Widen Its Healthcare Ad Network (Stocktwits)
08:00AM	OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath (GlobeNewswire)
Sep-14-26 08:00AM	OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience Intelligence (GlobeNewswire) +7.13%
07:30AM	Loading…
Sep-08-26 07:30AM	OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference (GlobeNewswire)
Sep-02-26 07:30AM	OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor (GlobeNewswire)
Aug-13-26 01:03AM	OptimizeRx Corp (OPRX) (Q2 2026) Earnings Call Highlights: Navigating Revenue Headwinds with ... (GuruFocus.com) +24.72%
Aug-12-26 04:05PM	OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth (GlobeNewswire)
04:01PM	OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance (GlobeNewswire)
Aug-11-26 09:24AM	Earnings To Watch: OptimizeRx Corp (OPRX) Q2 2026 -- GF Value Sees 106% Upside (GuruFocus.com)
Jul-29-26 07:30AM	OptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ET (GlobeNewswire)
Jul-23-26 07:30AM	OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer (GlobeNewswire)
Jun-30-26 07:30AM	OptimizeRx Launches CopayCue, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent (GlobeNewswire) +5.34%
Jun-25-26 07:30AM	OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms (GlobeNewswire)
08:33AM	Loading…
Jun-09-26 08:33AM	OptimizeRx: A Good Business That Has Not Yet Earned Back Investor Trust (GuruFocus.com)
Jun-01-26 07:30AM	OptimizeRx to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-21-26 07:30AM	DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx's Authenticated EHR Network (GlobeNewswire)
May-13-26 04:46PM	OptimizeRx Expands EHR Advertising Reach With New DSP Integration (Quartz) -22.48% +5.39%
01:02AM	OptimizeRx Corp (OPRX) Q1 2026 Earnings Call Highlights: Strong AI Growth Amid Revenue Challenges (GuruFocus.com)
May-12-26 04:01PM	OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance (GlobeNewswire)
May-11-26 09:22AM	What To Expect From OptimizeRx Corp (OPRX) Q1 2026 Earnings (GuruFocus.com)
07:30AM	OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale (GlobeNewswire)
Apr-29-26 04:05PM	OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report (GlobeNewswire)
Apr-28-26 08:00AM	OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ET (GlobeNewswire)
Apr-14-26 08:21PM	OPRX Cuts Revenue Outlook: Temporary Reset or Structural Concern? (Quartz) +5.79%
Apr-08-26 04:05PM	OptimizeRx Appoints Mary Varghese Presti to Board of Directors (GlobeNewswire) -5.23%
Mar-06-26 01:09PM	OptimizeRx Warns Of Volatility From 'Most Favored Nation' Pricing Uncertainty (Benzinga) -10.49%
12:03AM	OptimizeRx Corp (OPRX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Mar-05-26 11:05PM	OptimizeRx Q4 Earnings Call Highlights (MarketBeat)
05:20PM	Loading…
05:20PM	OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates (Zacks)
05:04PM	UPDATE - OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
04:01PM	OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Mar-04-26 05:35PM	Smith Micro Software, Inc. (SMSI) Reports Q4 Loss, Misses Revenue Estimates (Zacks) +7.51%
07:23AM	Earnings To Watch: OptimizeRx Corp (OPRX) Reports Q4 2025 Result (GuruFocus.com)
Feb-26-26 05:15PM	Intuit (INTU) Q2 Earnings and Revenues Top Estimates (Zacks)
Feb-05-26 08:00AM	OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET (GlobeNewswire)
06:31AM	Strength Seen in OptimizeRx (OPRX): Can Its 7.5% Jump Turn into More Strength? (Zacks)
Jan-08-26 02:00PM	OptimizeRx (OPRX): Clinical Network Growth Drives 37% Reach Boost Amid Analyst Upgrades (Insider Monkey)
Jan-07-26 08:00AM	OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing (GlobeNewswire)
Dec-17-25 04:30AM	OptimizeRx Continues Expansion of the Company's Point-Of-Care Network (GlobeNewswire)
Nov-17-25 06:51AM	New Strong Buy Stocks for Nov. 17: ROKU, AVPT, and More (Zacks)
Nov-07-25 12:02AM	OptimizeRx Corp (OPRX) Q3 2025 Earnings Call Highlights: Transitioning to Predictive Revenue ... (GuruFocus.com) -17.37%
Nov-06-25 06:15PM	OptimizeRx Corp. (OPRX) Tops Q3 Earnings and Revenue Estimates (Zacks)
04:01PM	OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance (GlobeNewswire)
Nov-05-25 07:51AM	Earnings To Watch: OptimizeRx Corp (OPRX) Reports Q3 2025 Result (GuruFocus.com)
Oct-20-25 08:00AM	OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET (GlobeNewswire)
Oct-02-25 12:00PM	OptimizeRx Corp. (OPRX) is a Great Momentum Stock: Should You Buy? (Zacks) -7.27%
Sep-30-25 10:05AM	OptimizeRx Bets on AI and Workflow Integration - Will This Pay Off? (Zacks)
Sep-10-25 07:30AM	OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference (GlobeNewswire)
Sep-09-25 04:05PM	OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising (GlobeNewswire)
Sep-05-25 09:23AM	Best Growth Stocks to Buy for September 5th (Zacks)
Sep-03-25 07:54AM	Best Growth Stocks to Buy for September 3rd (Zacks)
Sep-01-25 12:00PM	What Makes OptimizeRx Corp. (OPRX) a Strong Momentum Stock: Buy Now? (Zacks)
Aug-28-25 04:49PM	Stock Market Today: Nasdaq Up, S&P 500 Etches Record High As Lumentum Soars; Nvidia Ends Well Off Lows (Live Coverage) (Investor's Business Daily)
Aug-21-25 12:00PM	All You Need to Know About OptimizeRx (OPRX) Rating Upgrade to Strong Buy (Zacks)
10:00AM	Best Momentum Stock to Buy for August 21st (Zacks)
Aug-19-25 07:30AM	OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth (GlobeNewswire) -6.95%
Aug-07-25 05:55PM	OptimizeRx Corp. (OPRX) Surpasses Q2 Earnings and Revenue Estimates (Zacks) +34.74%
04:01PM	OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance (GlobeNewswire)
12:14PM	Shopify Q2 Earnings Beat Estimates, Revenues Jump Y/Y, Shares Rise (Zacks)
11:45AM	MKSI Q2 Earnings Beat Estimates, Revenues Rise Y/Y, Shares Rise (Zacks)
09:52AM	Fastly Posts Narrower Loss in Q2 Earnings, Revenues Rise Y/Y (Zacks)
09:19AM	Best Growth Stocks to Buy for August 7th (Zacks)
Aug-06-25 06:30PM	Smith Micro Software, Inc. (SMSI) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
12:42PM	AMD Q2 Earnings Beat Estimates, Revenues Up Y/Y, Shares Fall (Zacks)
Aug-05-25 09:06AM	Best Growth Stocks to Buy for August 5th (Zacks)
Aug-01-25 05:02AM	Best Growth Stocks to Buy for August 1st (Zacks)
Jul-31-25 02:56PM	Bull Of The Day: OptimizeRX (OPRX) (Zacks)
08:39AM	Does OptimizeRx Have a Moat in the Crowded HealthTech Space? (Zacks)
Jul-30-25 08:25AM	Blackbaud (BLKB) Q2 Earnings and Revenues Surpass Estimates (Zacks)
Jul-28-25 08:41AM	Take the Zacks Approach to Beat the Markets: AngloGold Ashanti, Caterpillar & Hershey in Focus (Zacks)
Jul-25-25 08:41AM	OPRX Delivers Solid Q1 Earnings: But Can It Sustain the Momentum? (Zacks)
Jul-22-25 09:21AM	Best Growth Stocks to Buy for July 22nd (Zacks)
Jul-18-25 08:34AM	Can OPRX's Patient Engagement Tools Win Amid Fierce Competition? (Zacks) -7.29%
Jul-17-25 07:30AM	OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET (GlobeNewswire)
Jul-16-25 09:30AM	OPRX vs. GDRX: Which Health Tech Stock Has Stronger Revenue Momentum? (Zacks) +9.25%
08:22AM	Synopsys (SNPS) Moves 3.6% Higher: Will This Strength Last? (Zacks)
Jul-12-25 07:30AM	'Story' stocks are smoking hot in 2025. This is how it could end badly for investors. (MarketWatch)
Jul-11-25 08:01AM	OptimizeRx Bets on AI and Workflow Integration: Will This Pay Off? (Zacks)
Jul-09-25 08:24AM	Best Growth Stocks to Buy for July 9th (Zacks)
Jul-04-25 09:49AM	Can OptimizeRx Maintain Profit Growth Amid Evolving Pharma Spend? (Zacks)
Jul-03-25 10:33AM	OPRX Shares Rise 69.3% in 3 Months: Time to Bet on the Stock? (Zacks)
Jun-25-25 07:41AM	Best Growth Stocks to Buy for June 25th (Zacks)
Jun-24-25 07:30AM	OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors (GlobeNewswire)
Jun-20-25 10:13AM	Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions (Business Wire)
Jun-18-25 03:00AM	Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions (Business Wire)
Jun-06-25 12:00PM	Here's Why OptimizeRx Corp. (OPRX) is a Great Momentum Stock to Buy (Zacks)
Jun-04-25 05:52AM	New Strong Buy Stocks for June 4th (Zacks)
May-23-25 10:54AM	DSGX's Solution Used by ArrowXL to Boost Last Mile Delivery (Zacks)
May-22-25 12:20PM	Earnings Estimates Rising for OptimizeRx (OPRX): Will It Gain? (Zacks)
May-16-25 07:30AM	OptimizeRx to Participate in Upcoming Investor Conferences (GlobeNewswire) +7.32%
May-13-25 08:08AM	Q1 2025 OptimizeRx Corp Earnings Call (Thomson Reuters StreetEvents) +19.67%
03:08AM	OptimizeRx Corp (OPRX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Shifts (GuruFocus.com)
May-12-25 05:35PM	OptimizeRx Corp. (OPRX) Beats Q1 Earnings and Revenue Estimates (Zacks) -7.91%
04:05PM	OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance (GlobeNewswire)
May-09-25 09:43AM	Earnings To Watch: OptimizeRx Corp (OPRX) Reports Q1 2025 Result (GuruFocus.com)
May-01-25 04:05PM	OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report (GlobeNewswire) +5.70%
Apr-30-25 05:15PM	Microsoft (MSFT) Q3 Earnings and Revenues Beat Estimates (Zacks)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Stelmakh Edward	Chief Finance & Strat Officer	Dec 19 '25	Option Exercise	0.00	5,237	0	128,218	Dec 22 10:10 AM
Stelmakh Edward	Chief Finance & Strat Officer	Dec 19 '25	Sale	13.51	1,388	18,752	126,830	Dec 22 10:10 AM
Silvestro Stephen L	Chief Executive Officer	Dec 19 '25	Option Exercise	0.00	6,546	0	195,462	Dec 22 10:10 AM
Odence-Ford Marion	Chief Legal & Admin Officer	Dec 19 '25	Option Exercise	0.00	3,928	0	94,526	Dec 22 10:09 AM
Besch Doug	Chief Product & Tech Officer	Dec 19 '25	Option Exercise	0.00	1,964	0	71,536	Dec 22 10:07 AM

OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.

CEO & DirectorMr. Stephen L. Silvestro

M.B.A.Mr. Edward Stelmakh C.M.A.

AdvisorMs. Theresa Greco

Chief Operating OfficerMr. Brendan Merrell

Chief Legal & Administrative OfficerMs. Marion K Odence-Ford

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

OptimizeRx Corp

Upgrade your Finviz experience